“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Vaccinologist and director of the Mayo Clinic’s Vaccine Research Group, Gregory M. Poland, MD, who is a leading vaccine developer and pro-mandatory vaccination proponent, has called for further research into the link between COVID-19 vaccination and hearing loss, as well as other auditory conditions such as tinnitus (ringing in the ears). Dr. Poland experienced a […]
In April 2021, the Biden administration made an announcement that the federal government would not be mandating a vaccine passport system in the United States. White House press secretary Jen Psaki stated: Let me be very clear on this, I know there’s been lots of questions. The government is not now, nor will we be, […]
A new study published in the journal JAMA Otolaryngology-Head & Neck Surgery published on Feb. 24, 2022 has found a possible association between Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic and sudden sensorineural hearing loss (SSNHL). The retrospective cohort study of 2 ,602, 557 patients in Israel suggested a slight increased risk of SSNHL.1 […]
Two years into the global pandemic of the novel coronavirus SARS-CoV-2, there is scant guidance from government agencies, universities, or professional medical organizations to help individuals recover from the SARS-CoV-2 infection that causes COVID-19 without the need for hospitalization. The U.S. Centers for Disease Control and Prevention (CDC), which recommends monoclonal antibodies for high-risk individuals […]
On Jan. 4, 2022, one of the top ranked hospitals in United States, Mayo Clinic, terminated 700 of its employees for refusing to get COVID-19 vaccinations. The 700 terminated employees represent approximately one percent of the hospital’s workforce.1 The hospital issued the following statement: While final numbers are still not available, nearly 99% of staff […]
Pfizer, Inc. reported that the company sold $7.8 billion worth of their COVID-19 biologic BNT162b2 in the second quarter of this year raising the company’s 2021 sales forecast for the two-dose vaccine to $33.5 billion from the previously estimated $26 billion.1 The $7.8 billion from direct sales of the shot is split with its German […]
The Israeli Health Ministry is evaluating cases of heart inflammation in people in Israel who have received Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19. In a preliminary study, led by Dror Mevorach, MD head of one of the COVID-19 units at Hadassah Hospital Ein Kerem in Jerusalem, 62 cases of myocarditis—inflammation of the […]
Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary. […]